Gary Lehr
Visit Investigator ProfileInvestigation Details
Detailed Analysis
Gary Lehr is detailed and meticulous, focusing on the precision of bioanalytical methods, the accuracy of SOPs and the quality control of assays. He places a high premium on the importance of avoiding potential data manipulation and practices that might compromise data integrity.
FDA investigator 'Gary Lehr' shows a keen emphasis on bioanalytical method validation and assay quality control. He is particularly focused on the precise use and management of SOPs and reference standards. He emphasizes accuracy and precision in laboratory setups, especially when dealing with calibration standards, assay interference, and usage of stock solutions. His observations indicate a focus on the validity of the data obtained and the maintenance of integrity in the processes.
Unlock Insights from 483s & Stay Audit Ready with FDA Tracker
Monitor FDA Six Systems, Analyse 483s with Observations, Investigators & Companies